tiprankstipranks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
VBIO
Valion Bio
RESEARCH TOOLSreports
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Financial Statements

169 Followers

Valion Bio Financial Overview

Valion Bio's market cap is currently $2.72M. The company's EPS TTM is $-0.05; its P/E ratio is -2.45; Valion Bio is scheduled to report earnings on August 17, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 22Mar 20Mar 19Mar 18
Income Statement
Total Revenue$ 382.00K$ 0.00$ 0.00$ 0.00$ 102.42K
Gross Profit$ 32.00K$ 0.00$ 0.00$ 0.00$ 24.48K
Operating Income$ -768.00K$ -2.34M$ -3.69M$ -4.57M$ -4.40M
EBITDA$ -768.00K$ -880.85K$ -3.69M$ -4.43M$ -4.31M
Net Income$ 0.00$ -880.85K$ -4.37M$ -20.14M$ -4.31M
Balance Sheet
Cash & Short-Term Investments$ 1.28M$ 884.14K$ 2.39M$ 5.98M$ 656.29K
Total Assets$ 119.68M$ 896.83K$ 2.57M$ 6.08M$ 675.79K
Total Debt$ 500.00K$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -783.12K$ -884.14K$ -2.39M$ -5.98M$ -656.29K
Total Liabilities$ 85.86M$ 33.44K$ 1.28M$ 1.05M$ 353.52K
Stockholders' Equity$ 20.38M$ 863.39K$ 1.28M$ 5.02M$ 322.27K
Cash Flow
Free Cash Flow$ -982.05K$ -1.61M$ -3.59M$ -3.67M$ -2.89M
Operating Cash Flow$ -982.05K$ -1.61M$ -3.59M$ -3.67M$ -2.89M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 141.54K$ 0.00
Financing Cash Flow$ 155.00K$ 96.99K$ 0.00$ 8.85M$ 2.39M
Currency in USD

Valion Bio Earnings and Revenue History

Income Statement >

Valion Bio Debt to Assets

Balance Sheet >

Valion Bio Cash Flow

Cash Flow >

Valion Bio Forecast EPS vs Actual EPS

Earnings >